JPWO2021069036A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021069036A5
JPWO2021069036A5 JP2022521536A JP2022521536A JPWO2021069036A5 JP WO2021069036 A5 JPWO2021069036 A5 JP WO2021069036A5 JP 2022521536 A JP2022521536 A JP 2022521536A JP 2022521536 A JP2022521536 A JP 2022521536A JP WO2021069036 A5 JPWO2021069036 A5 JP WO2021069036A5
Authority
JP
Japan
Prior art keywords
module
nicotine
water
lozenge
compressed oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022521536A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551314A (ja
JP7574286B2 (ja
Publication date
Priority claimed from US16/599,629 external-priority patent/US11759419B2/en
Application filed filed Critical
Publication of JP2022551314A publication Critical patent/JP2022551314A/ja
Publication of JPWO2021069036A5 publication Critical patent/JPWO2021069036A5/ja
Application granted granted Critical
Publication of JP7574286B2 publication Critical patent/JP7574286B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022521536A 2019-10-11 2020-04-17 圧縮ニコチンロゼンジ Active JP7574286B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/599,629 2019-10-11
US16/599,629 US11759419B2 (en) 2019-10-11 2019-10-11 Compressed nicotine lozenge
PCT/DK2020/050103 WO2021069036A1 (en) 2019-10-11 2020-04-17 Compressed nicotine lozenge

Publications (3)

Publication Number Publication Date
JP2022551314A JP2022551314A (ja) 2022-12-08
JPWO2021069036A5 true JPWO2021069036A5 (zh) 2023-04-21
JP7574286B2 JP7574286B2 (ja) 2024-10-28

Family

ID=70464804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022521536A Active JP7574286B2 (ja) 2019-10-11 2020-04-17 圧縮ニコチンロゼンジ

Country Status (12)

Country Link
US (2) US11759419B2 (zh)
EP (2) EP4445897A2 (zh)
JP (1) JP7574286B2 (zh)
KR (1) KR20220080165A (zh)
CN (1) CN114630653A (zh)
AU (2) AU2020363748B2 (zh)
BR (1) BR112022006691A2 (zh)
CA (1) CA3154225A1 (zh)
FI (1) FI3923910T3 (zh)
MX (1) MX2022004349A (zh)
WO (1) WO2021069036A1 (zh)
ZA (1) ZA202204081B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
WO2024156323A1 (en) * 2023-01-27 2024-08-02 Fertin Pharma A/S An adhesive oral disc for sustained release of cannabinoids
WO2024156906A1 (en) * 2023-01-27 2024-08-02 Philip Morris Products S.A. System for oral delivery of an active ingredient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
ES2592882T3 (es) 2008-10-14 2016-12-02 Mcneil Ab Forma de dosificación intra-oral de múltiples porciones y uso de la misma
AU2010238945B2 (en) 2009-04-24 2013-10-24 Omya International Ag Particulate material for controlled release of active ingredients
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
CA2916077C (en) 2015-12-22 2023-06-20 Euro-Pharm International Canada Inc. Nicotine-containing solid oral formulations and uses thereof
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
CN109952092B (zh) 2016-11-18 2022-08-23 费尔廷制药公司 包含独立的黏合剂和赤藓糖醇的片剂
CA3062146A1 (en) 2017-05-22 2018-11-29 Johnson & Johnson Consumer Inc. Lozenge dosage form

Similar Documents

Publication Publication Date Title
JP2640570B2 (ja) 強度が増加した錠剤の製造
JP5893405B2 (ja) ニコチンロゼンジ組成物
RU2376983C2 (ru) Гастроретентивные композиции и способ их изготовления
US8591955B2 (en) Orally rapidly disintegrating tablet that contains two or more types of particles
US20230321113A1 (en) Pharmaceutical solid preparation comprising benzazepines and production method thereof
FI3923910T3 (fi) Puristettu nikotiinipastilli
JP2006077018A5 (zh)
JP2001058944A (ja) 速崩壊性固形製剤
JP6488003B2 (ja) 安定なモンテルカスト溶液
WO2015115453A1 (ja) 口腔内速崩壊性固形製剤用組成物
CN102858327A (zh) 口腔剂型
JPWO2021069036A5 (zh)
US9301959B2 (en) Orally dispersible tablet containing compacted sildenafil base
JP5466880B2 (ja) 口腔内崩壊錠
JP6623753B2 (ja) 炭酸ランタンを含む口腔内崩壊錠
JP2007161706A (ja) 安中散含有錠剤
WO2013109225A1 (en) Pharmaceutical tablet formulations comprising ceftibuten
JP2010202579A (ja) アカルボースを含有する口腔内崩壊剤
JP2018193348A (ja) 炭酸ランタンを含む口腔内崩壊錠
EP2238974B9 (en) Granulate for the formulation of orodispersible tablets
JP2018118909A (ja) プレガバリン含有医薬組成物
JP2019031491A (ja) 糖尿病治療剤
TWI776177B (zh) 口腔內崩散錠的製造方法及口腔內崩散錠
JP5502358B2 (ja) 口腔内速崩壊性錠剤およびその製造方法
WO2005067895A1 (en) Controlled release pharmaceutical compositions